Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine.
Vansteenkiste JF, Vandebroek JE, Nackaerts KL, Weynants P, Valcke YJ, Verresen DA, Devogelaere RC, Marien SA, Humblet YP, Dams NL; Leuven Lung Cancer Group. Vansteenkiste JF, et al. Among authors: humblet yp. Ann Oncol. 2001 Sep;12(9):1221-30. doi: 10.1023/a:1012208711013. Ann Oncol. 2001. PMID: 11697832 Free article. Clinical Trial.
Dose-dependent interleukin-3 stimulation of thrombopoiesis and neutropoiesis in patients with small-cell lung carcinoma before and following chemotherapy: a placebo-controlled randomized phase Ib study.
D'Hondt V, Weynants P, Humblet Y, Guillaume T, Canon JL, Beauduin M, Duprez P, Longueville J, Müll R, Chatelain C, et al. D'Hondt V, et al. J Clin Oncol. 1993 Nov;11(11):2063-71. doi: 10.1200/JCO.1993.11.11.2063. J Clin Oncol. 1993. PMID: 8229120 Clinical Trial.
Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer: prolonged intrathoracic tumor control and high central nervous system relapse rate. Groupe d'Oncologie-Pneumologie Clinique de l'Université Catholique de Louvain, Brussels and Liège, Belgium.
van de Velde H, Bosquée L, Weynants P, Canon JL, Rosier JF, Humblet Y. van de Velde H, et al. Ann Oncol. 1999 Sep;10(9):1051-7. doi: 10.1023/a:1008306732232. Ann Oncol. 1999. PMID: 10572602 Free article. Clinical Trial.
Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
Humblet Y, Weynants P, Bosly A, Majois F, Duprez P, Francis C, Beauduin M, Machiels J, Gailly C, Delaunois L, et al. Humblet Y, et al. Med Oncol Tumor Pharmacother. 1989;6(3):207-12. doi: 10.1007/BF02985192. Med Oncol Tumor Pharmacother. 1989. PMID: 2559261 Clinical Trial.
114 results